实性肺结节的良恶性分析
Benign and Malignant Analysis of Solid Pulmonary Nodules
DOI: 10.12677/acm.2025.152418, PDF,   
作者: 刘芯宇, 兰 箭*：重庆医科大学附属第二医院呼吸与危重症医学科，重庆
关键词: 肺癌；肺结节；实性肺结节；良恶性；鉴别诊断；Lung Cancer； Lung Nodules； Solid Lung Nodules； Benign and Malignant； Differential Diagnosis
摘要: 肺癌是目前发病率和死亡率居首位的恶性肿瘤，对肺癌进行早期诊断是降低死亡率的关键。早期肺癌主要表现为肺结节，目前肺结节的检出率越来越高，而其中实性肺结节是检出最多的结节类型，对实性肺结节进行良恶性鉴别是重点。本文综述了实性肺结节的影像学及临床危险因素。影像学表现如结节大小、形态、边缘特征及生长速度，结合患者的年龄、吸烟史、家族史等临床信息，有助于评估实性肺结节的良恶性。
Abstract: Lung cancer is the malignant tumor with the highest morbidity and mortality rate, and early diagnosis of lung cancer is the key to reducing the mortality rate. Early lung cancer is mainly manifested as lung nodules, and the detection rate of lung nodules is getting higher and higher, among which solid lung nodules are the most frequently detected nodule type, and it is important to differentiate the benign and malignant nature of solid lung nodules. This article reviews the imaging and clinical risk factors of solid lung nodules. Imaging manifestations such as nodule size, morphology, margin characteristics, and growth rate, combined with clinical information such as the patient’s age, smoking history, and family history, are helpful in assessing the benign or malignant nature of solid lung nodules.
文章引用：刘芯宇, 兰箭. 实性肺结节的良恶性分析[J]. 临床医学进展, 2025, 15(2): 861-866. https://doi.org/10.12677/acm.2025.152418

参考文献

[1] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[2] Polanco, D., González, J., Gracia-Lavedan, E., Pinilla, L., Plana, R., Molina, M., et al. (2024) Multidisciplinary Virtual Management of Pulmonary Nodules. Pulmonology, 30, 239-246. [Google Scholar] [CrossRef] [PubMed]
[3] Tanner, N.T., Aggarwal, J., Gould, M.K., Kearney, P., Diette, G., Vachani, A., et al. (2015) Management of Pulmonary Nodules by Community Pulmonologists. Chest, 148, 1405-1414. [Google Scholar] [CrossRef] [PubMed]
[4] McWilliams, A., Tammemagi, M.C., Mayo, J.R., Roberts, H., Liu, G., Soghrati, K., et al. (2013) Probability of Cancer in Pulmonary Nodules Detected on First Screening CT. New England Journal of Medicine, 369, 910-919. [Google Scholar] [CrossRef] [PubMed]
[5] Sánchez, M., Benegas, M. and Vollmer, I. (2018) Management of Incidental Lung Nodules < 8 mm in Diameter. Journal of Thoracic Disease, 10, S2611-S2627. [Google Scholar] [CrossRef] [PubMed]
[6] Miyoshi, T., Aokage, K., Katsumata, S., Tane, K., Ishii, G. and Tsuboi, M. (2019) Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma. The Annals of Thoracic Surgery, 108, 249-255. [Google Scholar] [CrossRef] [PubMed]
[7] Liang, M., Tang, W., Xu, D.M., Jirapatnakul, A.C., Reeves, A.P., Henschke, C.I., et al. (2016) Low-Dose CT Screening for Lung Cancer: Computer-Aided Detection of Missed Lung Cancers. Radiology, 281, 279-288. [Google Scholar] [CrossRef] [PubMed]
[8] Yuan, H., Zou, Y., Gao, Y., Zhang, S., Zheng, X. and You, X. (2022) Correlation Analysis between Unenhanced and Enhanced CT Radiomic Features of Lung Cancers Presenting as Solid Nodules and Their Efficacy for Predicting Hilar and Mediastinal Lymph Node Metastases. Frontiers in Radiology, 2, Article ID: 911179. [Google Scholar] [CrossRef] [PubMed]
[9] Zhang, Y., Jheon, S., Li, H., Zhang, H., Xie, Y., Qian, B., et al. (2020) Results of Low-Dose Computed Tomography as a Regular Health Examination among Chinese Hospital Employees. The Journal of Thoracic and Cardiovascular Surgery, 160, 824-831.e4. [Google Scholar] [CrossRef] [PubMed]
[10] MacMahon, H., Naidich, D.P., Goo, J.M., Lee, K.S., Leung, A.N.C., Mayo, J.R., et al. (2017) Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology, 284, 228-243. [Google Scholar] [CrossRef] [PubMed]
[11] Mazzone, P.J. and Lam, L. (2022) Evaluating the Patient with a Pulmonary Nodule. JAMA, 327, 264-273. [Google Scholar] [CrossRef] [PubMed]
[12] Borghesi, A., Michelini, S., Scrimieri, A., Golemi, S. and Maroldi, R. (2019) Solid Indeterminate Pulmonary Nodules of Less than 300 mm3: Application of Different Volume Doubling Time Cut-Offs in Clinical Practice. Diagnostics, 9, Article No. 62. [Google Scholar] [CrossRef] [PubMed]
[13] Hammer, M.M., Gupta, S. and Byrne, S.C. (2023) Volume Doubling Times of Benign and Malignant Nodules in Lung Cancer Screening. Current Problems in Diagnostic Radiology, 52, 515-518. [Google Scholar] [CrossRef] [PubMed]
[14] Arshad, A., Saghir, Z., Borg, M., Juul, A.D. and Harders, S.M.W. (2024) Management of Incidental Pulmonary Nodules in CT Examination. Ugeskrift for Læger, 186, 1-9. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, R., Sun, H., Chen, B., Xu, R. and Li, W. (2021) Developing of Risk Models for Small Solid and Subsolid Pulmonary Nodules Based on Clinical and Quantitative Radiomics Features. Journal of Thoracic Disease, 13, 4156-4168. [Google Scholar] [CrossRef] [PubMed]
[16] Jung, Y.J., Kim, H., Kim, Y. and Cho, W. (2023) Clinical Correlates of Incidental Probable Benign Pulmonary Nodules with Diameters Less than 8 Mm in a Healthy Korean Cohort: A Retrospective Study. Journal of Clinical Medicine, 12, Article No. 7501. [Google Scholar] [CrossRef] [PubMed]
[17] Larici, A.R., Farchione, A., Franchi, P., Ciliberto, M., Cicchetti, G., Calandriello, L., et al. (2017) Lung Nodules: Size Still Matters. European Respiratory Review, 26, Article ID: 170025. [Google Scholar] [CrossRef] [PubMed]
[18] Chen, F., Liu, Y., Fu, B., Lv, F. and Chu, Z. (2021) Clinical and Computed Tomography (CT) Characteristics of Pulmonary Nodules Caused by Cryptococcal Infection. Infection and Drug Resistance, 14, 4227-4235. [Google Scholar] [CrossRef] [PubMed]
[19] Hu, B., Ren, W., Feng, Z., Li, M., Li, X., Han, R., et al. (2022) Correlation between CT Imaging Characteristics and Pathological Diagnosis for Subcentimeter Pulmonary Nodules. Thoracic Cancer, 13, 1067-1075. [Google Scholar] [CrossRef] [PubMed]
[20] Calheiros, J.L.L., de Amorim, L.B.V., de Lima, L.L., de Lima Filho, A.F., Ferreira Júnior, J.R. and de Oliveira, M.C. (2021) The Effects of Perinodular Features on Solid Lung Nodule Classification. Journal of Digital Imaging, 34, 798-810. [Google Scholar] [CrossRef] [PubMed]
[21] Sakakibara, Y., Suzuki, Y., Fujie, T., Akashi, T., Iida, T., Miyazaki, Y., et al. (2017) Radiopathological Features and Identification of Mycobacterial Infections in Granulomatous Nodules Resected from the Lung. Respiration, 93, 264-270. [Google Scholar] [CrossRef] [PubMed]
[22] Cai, J., Vonder, M., Heuvelmans, M.A., Pelgrim, G.J., Rook, M., Kramer, G., et al. (2022) CT Characteristics of Solid Pulmonary Nodules of Never Smokers versus Smokers: A Population-Based Study. European Journal of Radiology, 154, Article ID: 110410. [Google Scholar] [CrossRef] [PubMed]
[23] Susam, S., Çinkooğlu, A., Ceylan, K.C., Gürsoy, S., Kömürcüoğlu, B.E., Mertoğlu, A., et al. (2022) Comparison of Brock University, Mayo Clinic and Herder Models for Pretest Probability of Cancer in Solid Pulmonary Nodules. The Clinical Respiratory Journal, 16, 740-749. [Google Scholar] [CrossRef] [PubMed]
[24] Chu, Z., Sheng, B., Liu, M., Lv, F., Li, Q. and Ouyang, Y. (2016) Differential Diagnosis of Solitary Pulmonary Inflammatory Lesions and Peripheral Lung Cancers with Contrast-Enhanced Computed Tomography. Clinics, 71, 555-561. [Google Scholar] [CrossRef] [PubMed]
[25] Walter, J.E., Heuvelmans, M.A., ten Haaf, K., Vliegenthart, R., van der Aalst, C.M., Yousaf-Khan, U., et al. (2018) Persisting New Nodules in Incidence Rounds of the NELSON CT Lung Cancer Screening Study. Thorax, 74, 247-253. [Google Scholar] [CrossRef] [PubMed]
[26] Walter, J.E., Heuvelmans, M.A., de Jong, P.A., Vliegenthart, R., van Ooijen, P.M.A., Peters, R.B., et al. (2016) Occurrence and Lung Cancer Probability of New Solid Nodules at Incidence Screening with Low-Dose CT: Analysis of Data from the Randomised, Controlled NELSON Trial. The Lancet Oncology, 17, 907-916. [Google Scholar] [CrossRef] [PubMed]
[27] Pinsky, P.F., Gierada, D.S., Nath, P.H. and Munden, R. (2017) Lung Cancer Risk Associated with New Solid Nodules in the National Lung Screening Trial. American Journal of Roentgenology, 209, 1009-1014. [Google Scholar] [CrossRef] [PubMed]
[28] Horst, C., Nair, A. and Janes, S.M. (2019) Lessons on Managing Pulmonary Nodules from NELSON: We Have Come a Long Way. Thorax, 74, 427-429. [Google Scholar] [CrossRef] [PubMed]
[29] Chang, G., Chiu, C., Yu, C., Chang, Y., Chang, Y., Hsu, K., et al. (2024). The Lancet Respiratory Medicine, 12, 141-152.[CrossRef] [PubMed]
[30] Lin, H., Huang, Y., Yan, H., Yang, X., Zhong, W., Ye, H., et al. (2015) A Family History of Cancer and Lung Cancer Risk in Never-Smokers: A Clinic-Based Case-Control Study. Lung Cancer, 89, 94-98. [Google Scholar] [CrossRef] [PubMed]
[31] Mehta, H.J., Ravenel, J.G., Shaftman, S.R., Tanner, N.T., Paoletti, L., Taylor, K.K., et al. (2014) The Utility of Nodule Volume in the Context of Malignancy Prediction for Small Pulmonary Nodules. Chest, 145, 464-472. [Google Scholar] [CrossRef] [PubMed]
[32] Kwak, N., Park, C., Lee, J., Park, Y.S., Lee, S., Yim, J., et al. (2014) Lung Cancer Risk among Patients with Combined Pulmonary Fibrosis and Emphysema. Respiratory Medicine, 108, 524-530. [Google Scholar] [CrossRef] [PubMed]
[33] Cottin, V., Nunes, H., Brillet, P., Delaval, P., Devouassoux, G., Tillie-Leblond, I., et al. (2005) Combined Pulmonary Fibrosis and Emphysema: A Distinct Underrecognised Entity. European Respiratory Journal, 26, 586-593. [Google Scholar] [CrossRef] [PubMed]
[34] Li, N., Tan, F., Chen, W., Dai, M., Wang, F., Shen, S., et al. (2022) One-off Low-Dose CT for Lung Cancer Screening in China: A Multicentre, Population-Based, Prospective Cohort Study. The Lancet Respiratory Medicine, 10, 378-391. [Google Scholar] [CrossRef] [PubMed]

为你推荐